Orano Med LLC
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients (NCT05153772) | Orano Med LLC | 2021-12-21 |
| Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET (NCT03466216) | Orano Med LLC | 2018-02-05 |
Track Orano Med LLC automatically
Every clearance here is in the API, with alerts when new ones post.